StockData

China Pharma Holdings, Inc. (CPHI) stock

CPHINYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.50+0.02 (+4.17%)

Close on Nov 17, 2026Market cap $21.51MP/E –Yield –

China Pharma revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

China Pharma's revenue for the twelve months ending Jun 30, 2026 was $3.91M, down 11.0% year over year. For fiscal 2025 it was $4.14M, down 8.5% from the year before. Over ten years it grew -14.7% a year on average. The highest annual figure on record is $81.17M in fiscal 2011.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.14M-8.5%
FY2024Dec 31, 2024$4.53M-35.4%
FY2023Dec 31, 2023$7.01M-13.5%
FY2022Dec 31, 2022$8.10M-15.9%
FY2021Dec 31, 2021$9.64M-11.3%
FY2020Dec 31, 2020$10.87M-0.5%
FY2019Dec 31, 2019$10.92M-11.4%
FY2018Dec 31, 2018$12.33M-6.7%
FY2017Dec 31, 2017$13.21M-15.1%
FY2016Dec 31, 2016$15.57M-23.5%
FY2015Dec 31, 2015$20.35M-8.1%
FY2014Dec 31, 2014$22.13M-32.5%
FY2013Dec 31, 2013$32.81M-39.8%
FY2012Dec 31, 2012$54.51M-32.8%
FY2011Dec 31, 2011$81.17M+9.1%
FY2010Dec 31, 2010$74.39M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$948.34K-7.5%
Q1 FY2026Mar 31, 2026$983.54K-13.4%
Q4 FY2025Dec 31, 2025$1.23M+8.1%
Q3 FY2025Sep 30, 2025$756.22K-31.3%
Q2 FY2025Jun 30, 2025$1.03M+10.9%
Q1 FY2025Mar 31, 2025$1.14M-17.0%
Q4 FY2024Dec 31, 2024$1.13M-47.2%
Q3 FY2024Sep 30, 2024$1.10M-39.0%
Q2 FY2024Jun 30, 2024$924.94K-15.8%
Q1 FY2024Mar 31, 2024$1.37M-30.1%
Q4 FY2023Dec 31, 2023$2.15M-26.4%
Q3 FY2023Sep 30, 2023$1.80M-8.3%
Q2 FY2023Jun 30, 2023$1.10M-31.9%
Q1 FY2023Mar 31, 2023$1.96M+22.2%
Q4 FY2022Dec 31, 2022$2.92M+1.1%
Q3 FY2022Sep 30, 2022$1.97M-0.6%
Q2 FY2022Jun 30, 2022$1.61M-33.2%
Q1 FY2022Mar 31, 2022$1.60M-32.0%
Q4 FY2021Dec 31, 2021$2.89M-1.4%
Q3 FY2021Sep 30, 2021$1.98M-17.6%
Q2 FY2021Jun 30, 2021$2.42M-35.9%
Q1 FY2021Mar 31, 2021$2.36M+33.7%
Q4 FY2020Dec 31, 2020$2.93M-3.8%
Q3 FY2020Sep 30, 2020$2.40M+1.0%
Q2 FY2020Jun 30, 2020$3.77M+46.8%
Q1 FY2020Mar 31, 2020$1.76M-39.8%
Q4 FY2019Dec 31, 2019$3.05M-6.0%
Q3 FY2019Sep 30, 2019$2.38M+3.4%
Q2 FY2019Jun 30, 2019$2.57M-19.0%
Q1 FY2019Mar 31, 2019$2.93M-19.0%
Q4 FY2018Dec 31, 2018$3.24M-15.7%
Q3 FY2018Sep 30, 2018$2.30M-27.3%
Q2 FY2018Jun 30, 2018$3.17M+8.8%
Q1 FY2018Mar 31, 2018$3.62M+10.1%
Q4 FY2017Dec 31, 2017$3.85M-26.9%
Q3 FY2017Sep 30, 2017$3.16M+1.2%
Q2 FY2017Jun 30, 2017$2.92M–
Q1 FY2017Mar 31, 2017$3.29M–
Q4 FY2016Dec 31, 2016$5.26M–
Q3 FY2016Sep 30, 2016$3.13M–

More China Pharma figures

See a number that looks wrong?